Researchers Say Use Of RNA Signature Of Tuberculosis As Biomarker For Therapy Did Not Reduce Progression To Tuberculosis Over 15 Months

Infectious Disease Advisor (5/6, van Paridon) reports researchers used RISK11, “an RNA signature of tuberculosis,” in order “to discriminate between individuals with prevalent tuberculosis or progression to incident tuberculosis and individuals who remain...